secwatch.observer — SEC 8-K summary
======================================

Issuer:     Modular Medical, Inc. (MODD)
CIK:        0001074871
Form:       8-K
Filed at:   2021-08-16T23:59:59+00:00
Accession:  0001019056-21-000475
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Modular Medical appoints Lynn O'Connor Vos as CEO; founder DiPerna becomes Chairman and President
--------------------------------------------------------------------------------

- Paul DiPerna resigned as CEO effective Aug 11, 2021; remains Chairman, President, CFO, Secretary.
- Ellen O'Connor Vos appointed CEO; employment agreement: $250k cash + $50k deferred salary, $300k performance bonus.
- Vos granted option to purchase 1,087,354 shares at $4.06 (closing Aug 10); vesting 20% after 6 months, rest over 42 months.
- Vos previously CEO of Muscular Dystrophy Association and ghg|greyhealth group; focuses on digital health and patient advocacy.
- Company is development-stage insulin pump firm targeting commercial launch in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1074871/000101905621000475/0001019056-21-000475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1074871/000101905621000475/modular_8k.htm
  HTML page:      https://secwatch.observer/filing/0001019056-21-000475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer